OSTAZA Trademark

Trademark Overview

On Friday, May 3, 2013, a trademark application was filed for OSTAZA with the United States Patent and Trademark Office. The USPTO has given the OSTAZA trademark a serial number of 85922684. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 22, 2018. This trademark is owned by Glaxo Group Limited. The OSTAZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
ostaza

General Information

Serial Number85922684
Word MarkOSTAZA
Filing DateFriday, May 3, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 22, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 21, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "OSTAZA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 10, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, January 22, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 22, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017EXTENSION 5 GRANTED
Thursday, June 8, 2017EXTENSION 5 FILED
Tuesday, June 13, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 8, 2017TEAS EXTENSION RECEIVED
Tuesday, December 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 10, 2016EXTENSION 4 GRANTED
Thursday, December 1, 2016EXTENSION 4 FILED
Thursday, December 1, 2016TEAS EXTENSION RECEIVED
Tuesday, July 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 16, 2016EXTENSION 3 GRANTED
Tuesday, May 31, 2016EXTENSION 3 FILED
Thursday, July 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2016TEAS EXTENSION RECEIVED
Wednesday, December 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 15, 2015EXTENSION 2 GRANTED
Thursday, November 19, 2015EXTENSION 2 FILED
Friday, December 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 19, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 1, 2015EXTENSION 1 GRANTED
Monday, June 1, 2015EXTENSION 1 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Tuesday, December 16, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 21, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 16, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 15, 2014LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, September 8, 2014ASSIGNED TO LIE
Thursday, March 6, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, August 27, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 27, 2013LETTER OF SUSPENSION E-MAILED
Tuesday, August 27, 2013SUSPENSION LETTER WRITTEN
Wednesday, August 21, 2013ASSIGNED TO EXAMINER
Friday, May 10, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 7, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

ostaza pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological